Investors

Stock price graph
     

BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

View all »   RSSRecent Releases

Mar 26, 2015
BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology

Mar 24, 2015
BG Medicine Announces Fiscal Year 2014 Financial Results Release Date and Conference Call Information

View all »Events & Presentations

Mar 31, 2015 at 8:30 AM ET
Q4 2014 Earnings Call